U.S. flag

An official website of the United States government

NM_000277.3(PAH):c.428A>T (p.Asp143Val) AND Phenylketonuria

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Dec 22, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002014138.6

Allele description [Variation Report for NM_000277.3(PAH):c.428A>T (p.Asp143Val)]

NM_000277.3(PAH):c.428A>T (p.Asp143Val)

Gene:
PAH:phenylalanine hydroxylase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q23.2
Genomic location:
Preferred name:
NM_000277.3(PAH):c.428A>T (p.Asp143Val)
HGVS:
  • NC_000012.12:g.102877475T>A
  • NG_008690.2:g.85936A>T
  • NM_000277.3:c.428A>TMANE SELECT
  • NM_001354304.2:c.428A>T
  • NP_000268.1:p.Asp143Val
  • NP_001341233.1:p.Asp143Val
  • NC_000012.11:g.103271253T>A
Protein change:
D143V
Links:
dbSNP: rs199475572
NCBI 1000 Genomes Browser:
rs199475572
Molecular consequence:
  • NM_000277.3:c.428A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354304.2:c.428A>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Phenylketonuria (PKU)
Synonyms:
Phenylketonurias; Oligophrenia phenylpyruvica; Folling disease
Identifiers:
MONDO: MONDO:0009861; MedGen: C0031485; Orphanet: 716; OMIM: 261600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002304134Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 2, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

SCV004201972Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Dec 22, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The Spectrum of PAH Mutations and Increase of Milder Forms of Phenylketonuria in Sweden During 1965-2014.

Ohlsson A, Bruhn H, Nordenström A, Zetterström RH, Wedell A, von Döbeln U.

JIMD Rep. 2017;34:19-26. doi: 10.1007/8904_2016_4. Epub 2016 Jul 28.

PubMed [citation]
PMID:
27469133
PMCID:
PMC5509542

The study of the full spectrum of variants leading to hyperphenylalaninemia have revealed 10 new variants in the PAH gene.

Kuznetcova I, Gundorova P, Ryzhkova O, Polyakov A.

Metab Brain Dis. 2019 Dec;34(6):1547-1555. doi: 10.1007/s11011-019-00461-w. Epub 2019 Jul 22.

PubMed [citation]
PMID:
31332730
See all PubMed Citations (9)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002304134.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 143 of the PAH protein (p.Asp143Val). This variant is present in population databases (no rsID available, gnomAD 0.03%). This missense change has been observed in individuals with clinical features of phenylketonuria and/or hyperphenylalaninemia (PMID: 27469133, 31332730, 32668217). ClinVar contains an entry for this variant (Variation ID: 1510805). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PAH protein function with a positive predictive value of 80%. This variant disrupts the p.Asp143 amino acid residue in PAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8889583, 18937047, 21147011, 21953985). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004201972.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024